tiprankstipranks
Autolus Therapeutics (AUTL)
NASDAQ:AUTL
US Market
AUTL
Autolus Therapeutics
RESEARCH TOOLSreports
Want to see AUTL full AI Analyst Report?

Autolus Therapeutics (AUTL) Income Statement

949 Followers

Autolus Therapeutics Income Statement

Last quarter (Q4 2025), Autolus Therapeutics's total revenue was $24.25M, an increase of 83534.17% from the same quarter last year. In Q4, Autolus Therapeutics's net income was $-90.20M. See Autolus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 75.56M$ 10.12M$ 1.70M$ 6.19M$ 1.51M
Gross Profit
$ -21.03M$ -130.90M$ 1.70M$ 6.19M$ 1.51M
Operating Expenses
$ 260.41M$ 110.53M$ 181.40M$ 149.09M$ 141.88M
Depreciation and Amortization
$ 9.84M$ 7.72M$ 6.57M$ 7.42M$ 8.46M
EBITDA
$ -271.60M$ -233.07M$ -156.77M$ -132.24M$ -132.47M
Operating Income
$ -281.44M$ -241.43M$ -179.70M$ -142.89M$ -140.37M
Other Income/Expenses
$ -15.41M$ 22.29M$ -28.70M$ -5.67M$ -1.66M
Pretax Income
$ -296.85M$ -219.13M$ -208.40M$ -148.57M$ -142.04M
Net Income
$ -287.53M$ -220.66M$ -208.38M$ -148.84M$ -142.10M
Per Share Metrics
Basic EPS
$ -1.08$ -0.87$ -1.20$ -1.57$ -1.97
Diluted EPS
$ -1.08$ -0.87$ -1.20$ -1.57$ -1.97
Weighted Average Shares Outstanding
 266.14M 255.16M 173.94M 94.99M 72.08M
Weighted Average Shares Outstanding (Diluted)
 266.14M 255.16M 173.94M 94.99M 72.08M
Currency in USD

Autolus Therapeutics Earnings and Revenue History